Products

NewsGator

AI-native

One story per real-world event.

newsgator.app Source App StoreEntertainment & Media / News & Media

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Freemium model, plan pricing not identified yet
Launched
27d ago
2026-10-23 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    One story per real-world event, not five duplicate articles.

    Oct 23 · 27d agoLaunch page

    At the time: <5K visits/mo

Open Source & Self-Hosting

GitHub · MCP / Skill
Last commit 2026-11-07
GitHub Stars
Public repo
Forks
—
License
See repository
Primary language
—

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered Unknown

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-07 · Source page

Pages & changes

Tracked since 2026-10-23

Key pages

Weekly snapshots
Home
www.newsgator.app/ Snapshot 2026-11-08

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does NewsGator get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is NewsGator and what platforms does it support?
NewsGator is catalogued under News & Media: One story per real-world event. Supported platforms: Mobile App.
Is NewsGator open source?
NewsGator has a public repository (https://github.com/Tekka90/NewsGator) with its source repository published.Source

Related products in this category

Entertainment & Media / News & Media

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.